• Fang C, Lee KK, Nietupski R, Bates RH, Fernandez-Menendez R, Lopez-Roman EM, Guijarro-Lopez L, Yin Y, Peng Z, Gomez JE, Fisher S, Barros-Aguirre D, Hubbard BK, Serrano-Wu MH, Hung DT Discovery of heterocyclic replacements for the coumarin core of anti-tubercular FadD32 inhibitors. Bioorg Med Chem Lett. 2018;28(22):3529-3533 - PMID: 30316633 - PMCID: PMC6233306 - DOI: 10.1016/j.bmcl.2018.09.037

  • Ma P, Laibinis HH, Ernst CM, Hung DT Carbapenem resistance caused by high-level expression of OXA-663 β-lactamase in an OmpK36-deficient Klebsiella pneumoniae clinical isolate. Antimicrob Agents Chemother. 2018;62(11):ePub - PMID: 30126962 - PMCID: PMC6201135 - DOI: 10.1128/AAC.01281-18

  • Bhattacharyya RP, Thakku SG, Hung DT Harnessing CRISPR Effectors for Infectious Disease Diagnostics. ACS Infect Dis. 2018;4(9):1278-1282 - PMID: 30113801 - DOI: 10.1021/acsinfecdis.8b00170

  • Clatworthy AE, Romano KP, Hung DT Whole-organism phenotypic screening for anti-infectives promoting host health. Nat Chem Biol. 2018;14(4):331-341 - PMID: 29556098 - PMCID: PMC9843822 - DOI: 10.1038/s41589-018-0018-3

  • Wellington S, Hung DT The expanding diversity of Mycobacterium tuberculosis drug targets. ACS Infect Dis. 2018;4(5):696-714 - PMID: 29412643 - DOI: 10.1021/acsinfecdis.7b00255